Hypermethylation of the MLH1 promoter and loss of protein expression was also shown in a significant fraction of clinical samples of ovarian tumors, wherein the suggestion was made that hypermethylation of MLH1 could be a contributing factor to acquired platinum resistance, which is frequently observed in ovarian carcinoma. The gene discussed is MLH1; the disease is ovarian neoplasm.